Fabricio Ferreira de Oliveira, M.D., B.B.A, M.Sc., Ph.D.
Executive Medical Director
Elysian Clinic São Paulo, Brazil
Zahinoor Ismail, M.D. FRCPC
Professor of Psychiatry, Neurology, Epidemiology and Pathology
Hotchkiss Brain Institute and O’Brien Institute for Public Health
Cumming School of Medicine, University of Calgary
Fabrizia D'Antonio, MD, PhD
Sapienza University of Rome
Maryam Ghahremani, PhD
University of Calgary
|Credit Provided by||Rush University|
|Funding Statement||Earn complimentary CME credit.|
|Copyright Statement with Logo||Home Office
Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
Alzheimer's Association is a not-for-profit 501(c)(3) organization.
© 2021 Alzheimer’s Association®. All rights reserved.
All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies and Standards for Commercial Support. Recommendations involving clinical medicine in a Continuing Medical Education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis.
This CME/CE activity might describe the off-label, investigational or experimental use of medications that may exceed their FDA- approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. RUSH University Medical Center requires the speaker to disclose that a product is not labeled for the use under discussion.
|Target Audience / Intended Audience||This activity is intended to meet the educational needs of psychologists, primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.|
|Statement of Need / Activity Purpose||
The purpose of this webinar is to enhance knowledge on the potential use of biofluid biomarkers to assess neuropsychiatric diagnoses and drug response in dementia with Lewy bodies as well as in preclinical and prodromal Alzheimer's disease.
ACTIVITY - EN514-0223
Upon completion of this webinar you will learn:
|Method of Participation||
This curriculum will take approximately 60 minutes to complete. To receive maximum credit, participants are required to view the presentation in its entirety. Upon completion of the activity and evaluation form, a certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact email@example.com
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Rush University Medical Center designates enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University Medical Center designates this enduring material for 1.00 CE credits in psychology.
Disclosures - Faculty reports the following relationship(s)
Dr. Fabricio Ferreira de Oliveira has disclosed consultancies to Gerson Lehrman Group - GLG, Atheneum Partners, Guidepoint, and Lionbridge. He is also Associate Editor (paid) of Clinical Neurology & Neurosurgery (Elsevier), Associate Editor (unpaid) of Frontiers in Neuroscience (Frontiers Media) and the Journal of Alzheimer's Disease (IOS Press), Academic Editor (unpaid) of Medicine (Wolters Kluwer Health).
Dr. Zahinoor Ismail has disclosed consultancies to Acadia, Biogen, Roche - paid to institution; Lundbeck/Otsuka - paid personally
Dr. Fabrizia D'Antonio has no relevant financial disclosures;
Dr. Maryam Ghahremani has no relevant financial disclosures;
Dr. Claire Sexton, Alzheimer’s Association staff, has no relevant financial disclosures.
|Hardware and Software Requirements||